The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening
Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality. To assess the effect of personalising the content of a...
Gespeichert in:
| Veröffentlicht in: | PloS one 2016-04, Vol.11 (4), p.e0152999-e0152999 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0152999 |
|---|---|
| container_issue | 4 |
| container_start_page | e0152999 |
| container_title | PloS one |
| container_volume | 11 |
| creator | Salkeld, Glenn Cunich, Michelle Dowie, Jack Howard, Kirsten Patel, Manish I Mann, Graham Lipworth, Wendy |
| description | Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality.
To assess the effect of personalising the content of a decision aid for prostate cancer screening using the Prostate Specific Antigen (PSA) test.
Randomized controlled trial.
Australia.
1,970 men aged 40-69 years were approached to participate in the trial.
1,447 men were randomly allocated to either a standard decision aid with a fixed set of five attributes or a personalised decision aid with choice over the inclusion of up to 10 attributes.
To determine whether there was a difference between the two groups in terms of: 1) the emergent opinion (generated by the decision aid) to have a PSA test or not; 2) self-rated decision quality after completing the online decision aid; 3) their intention to undergo screening in the next 12 months. We also wanted to determine whether men in the personalised choice group made use of the extra decision attributes.
5% of men in the fixed attribute group scored 'Have a PSA test' as the opinion generated by the aid, as compared to 62% of men in the personalised choice group (χ2 = 569.38, 2df, p< 0001). Those men who used the personalised decision aid had slightly higher decision quality (t = 2.157, df = 1444, p = 0.031). The men in the personalised choice group made extensive use of the additional decision attributes. There was no difference between the two groups in terms of their stated intention to undergo screening in the next 12 months.
Together, these findings suggest that personalised decision support systems could be an important development in shared decision-making and patient-centered care.
Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612000723886. |
| doi_str_mv | 10.1371/journal.pone.0152999 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1779033849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A453452078</galeid><doaj_id>oai_doaj_org_article_b1ca67e863e34d988a5b450878198b46</doaj_id><sourcerecordid>A453452078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-8931715319e6bbb14dac7b5fc641907a362bdf95cbffa2b733a4884d923956133</originalsourceid><addsrcrecordid>eNqNk9-OEyEUxidG466rb2CUxMToRSsMwwx4YdLUf0026aat3hKGOdPSUOjCjFEfwaeW2u7amr0wXEDg930HDudk2VOCh4RW5M3a98EpO9x6B0NMWC6EuJedE0HzQZljev9ofZY9inGNMaO8LB9mZ3mFGSaYnGe_FitAM28B-RZdQYg-eZoIDRqvvNGAjEPvQZtovEPzfrv1oXuLRmimXOM35ucO9K4L3tq0XASj7M5JOTR11jj4Kx6ZBrU-oKvgY6c6QGPlNAQ01wHAGbd8nD1olY3w5DBfZF8-fliMPw8up58m49HlQJci7wZcUFIRRomAsq5rUjRKVzVrdVkQgStFy7xuWsF03bYqrytKVcF50YicClYSSi-y53vfrfVRHtIYJakqgSnlhUjEZE80Xq3lNpiNCj-kV0b-2fBhKVXojLYga6JVWQEvKdAUg3PF6oJhXnEieF2UyevdIVpfb6DRkJKl7Inp6YkzK7n032TB81wwlgxeHQyCv-4hdnJjogZrlQPf7-_NOU2_n9AX_6B3v-5ALVV6gHGtT3H1zlSOCkYLluOKJ2p4B5VGAxujU821Ju2fCF6fCBLTwfduqfoY5WQ--392-vWUfXnErkDZbhW97btUVPEULPagThUWA7S3SSZY7lrmJhty1zLy0DJJ9uz4g25FNz1CfwMDnBAk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779033849</pqid></control><display><type>article</type><title>The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Salkeld, Glenn ; Cunich, Michelle ; Dowie, Jack ; Howard, Kirsten ; Patel, Manish I ; Mann, Graham ; Lipworth, Wendy</creator><creatorcontrib>Salkeld, Glenn ; Cunich, Michelle ; Dowie, Jack ; Howard, Kirsten ; Patel, Manish I ; Mann, Graham ; Lipworth, Wendy</creatorcontrib><description>Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality.
To assess the effect of personalising the content of a decision aid for prostate cancer screening using the Prostate Specific Antigen (PSA) test.
Randomized controlled trial.
Australia.
1,970 men aged 40-69 years were approached to participate in the trial.
1,447 men were randomly allocated to either a standard decision aid with a fixed set of five attributes or a personalised decision aid with choice over the inclusion of up to 10 attributes.
To determine whether there was a difference between the two groups in terms of: 1) the emergent opinion (generated by the decision aid) to have a PSA test or not; 2) self-rated decision quality after completing the online decision aid; 3) their intention to undergo screening in the next 12 months. We also wanted to determine whether men in the personalised choice group made use of the extra decision attributes.
5% of men in the fixed attribute group scored 'Have a PSA test' as the opinion generated by the aid, as compared to 62% of men in the personalised choice group (χ2 = 569.38, 2df, p< 0001). Those men who used the personalised decision aid had slightly higher decision quality (t = 2.157, df = 1444, p = 0.031). The men in the personalised choice group made extensive use of the additional decision attributes. There was no difference between the two groups in terms of their stated intention to undergo screening in the next 12 months.
Together, these findings suggest that personalised decision support systems could be an important development in shared decision-making and patient-centered care.
Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612000723886.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0152999</identifier><identifier>PMID: 27050101</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Analysis ; Antigens ; Artificial intelligence ; Biology and Life Sciences ; Cancer ; Cancer screening ; Care and treatment ; Clinical decision making ; Clinical trials ; Customization ; Decision making ; Decision support systems ; Decision Support Techniques ; Diagnosis ; Health care costs ; Humans ; Internet ; Intervention ; Male ; Medical research ; Medical screening ; Medicine and Health Sciences ; Men ; Mens health ; Middle Aged ; Motivation ; Online Systems ; Patient Participation ; Prostate ; Prostate cancer ; Prostate specific antigen ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - diagnosis ; Public health ; Quality ; Quality assessment ; Randomization ; Research and Analysis Methods ; Screening ; Studies ; Systematic review</subject><ispartof>PloS one, 2016-04, Vol.11 (4), p.e0152999-e0152999</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Salkeld et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Salkeld et al 2016 Salkeld et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-8931715319e6bbb14dac7b5fc641907a362bdf95cbffa2b733a4884d923956133</citedby><cites>FETCH-LOGICAL-c692t-8931715319e6bbb14dac7b5fc641907a362bdf95cbffa2b733a4884d923956133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822955/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822955/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27050101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salkeld, Glenn</creatorcontrib><creatorcontrib>Cunich, Michelle</creatorcontrib><creatorcontrib>Dowie, Jack</creatorcontrib><creatorcontrib>Howard, Kirsten</creatorcontrib><creatorcontrib>Patel, Manish I</creatorcontrib><creatorcontrib>Mann, Graham</creatorcontrib><creatorcontrib>Lipworth, Wendy</creatorcontrib><title>The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality.
To assess the effect of personalising the content of a decision aid for prostate cancer screening using the Prostate Specific Antigen (PSA) test.
Randomized controlled trial.
Australia.
1,970 men aged 40-69 years were approached to participate in the trial.
1,447 men were randomly allocated to either a standard decision aid with a fixed set of five attributes or a personalised decision aid with choice over the inclusion of up to 10 attributes.
To determine whether there was a difference between the two groups in terms of: 1) the emergent opinion (generated by the decision aid) to have a PSA test or not; 2) self-rated decision quality after completing the online decision aid; 3) their intention to undergo screening in the next 12 months. We also wanted to determine whether men in the personalised choice group made use of the extra decision attributes.
5% of men in the fixed attribute group scored 'Have a PSA test' as the opinion generated by the aid, as compared to 62% of men in the personalised choice group (χ2 = 569.38, 2df, p< 0001). Those men who used the personalised decision aid had slightly higher decision quality (t = 2.157, df = 1444, p = 0.031). The men in the personalised choice group made extensive use of the additional decision attributes. There was no difference between the two groups in terms of their stated intention to undergo screening in the next 12 months.
Together, these findings suggest that personalised decision support systems could be an important development in shared decision-making and patient-centered care.
Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612000723886.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Antigens</subject><subject>Artificial intelligence</subject><subject>Biology and Life Sciences</subject><subject>Cancer</subject><subject>Cancer screening</subject><subject>Care and treatment</subject><subject>Clinical decision making</subject><subject>Clinical trials</subject><subject>Customization</subject><subject>Decision making</subject><subject>Decision support systems</subject><subject>Decision Support Techniques</subject><subject>Diagnosis</subject><subject>Health care costs</subject><subject>Humans</subject><subject>Internet</subject><subject>Intervention</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical screening</subject><subject>Medicine and Health Sciences</subject><subject>Men</subject><subject>Mens health</subject><subject>Middle Aged</subject><subject>Motivation</subject><subject>Online Systems</subject><subject>Patient Participation</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Prostate specific antigen</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Public health</subject><subject>Quality</subject><subject>Quality assessment</subject><subject>Randomization</subject><subject>Research and Analysis Methods</subject><subject>Screening</subject><subject>Studies</subject><subject>Systematic review</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9-OEyEUxidG466rb2CUxMToRSsMwwx4YdLUf0026aat3hKGOdPSUOjCjFEfwaeW2u7amr0wXEDg930HDudk2VOCh4RW5M3a98EpO9x6B0NMWC6EuJedE0HzQZljev9ofZY9inGNMaO8LB9mZ3mFGSaYnGe_FitAM28B-RZdQYg-eZoIDRqvvNGAjEPvQZtovEPzfrv1oXuLRmimXOM35ucO9K4L3tq0XASj7M5JOTR11jj4Kx6ZBrU-oKvgY6c6QGPlNAQ01wHAGbd8nD1olY3w5DBfZF8-fliMPw8up58m49HlQJci7wZcUFIRRomAsq5rUjRKVzVrdVkQgStFy7xuWsF03bYqrytKVcF50YicClYSSi-y53vfrfVRHtIYJakqgSnlhUjEZE80Xq3lNpiNCj-kV0b-2fBhKVXojLYga6JVWQEvKdAUg3PF6oJhXnEieF2UyevdIVpfb6DRkJKl7Inp6YkzK7n032TB81wwlgxeHQyCv-4hdnJjogZrlQPf7-_NOU2_n9AX_6B3v-5ALVV6gHGtT3H1zlSOCkYLluOKJ2p4B5VGAxujU821Ju2fCF6fCBLTwfduqfoY5WQ--392-vWUfXnErkDZbhW97btUVPEULPagThUWA7S3SSZY7lrmJhty1zLy0DJJ9uz4g25FNz1CfwMDnBAk</recordid><startdate>20160406</startdate><enddate>20160406</enddate><creator>Salkeld, Glenn</creator><creator>Cunich, Michelle</creator><creator>Dowie, Jack</creator><creator>Howard, Kirsten</creator><creator>Patel, Manish I</creator><creator>Mann, Graham</creator><creator>Lipworth, Wendy</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160406</creationdate><title>The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening</title><author>Salkeld, Glenn ; Cunich, Michelle ; Dowie, Jack ; Howard, Kirsten ; Patel, Manish I ; Mann, Graham ; Lipworth, Wendy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-8931715319e6bbb14dac7b5fc641907a362bdf95cbffa2b733a4884d923956133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Antigens</topic><topic>Artificial intelligence</topic><topic>Biology and Life Sciences</topic><topic>Cancer</topic><topic>Cancer screening</topic><topic>Care and treatment</topic><topic>Clinical decision making</topic><topic>Clinical trials</topic><topic>Customization</topic><topic>Decision making</topic><topic>Decision support systems</topic><topic>Decision Support Techniques</topic><topic>Diagnosis</topic><topic>Health care costs</topic><topic>Humans</topic><topic>Internet</topic><topic>Intervention</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical screening</topic><topic>Medicine and Health Sciences</topic><topic>Men</topic><topic>Mens health</topic><topic>Middle Aged</topic><topic>Motivation</topic><topic>Online Systems</topic><topic>Patient Participation</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Prostate specific antigen</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Public health</topic><topic>Quality</topic><topic>Quality assessment</topic><topic>Randomization</topic><topic>Research and Analysis Methods</topic><topic>Screening</topic><topic>Studies</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salkeld, Glenn</creatorcontrib><creatorcontrib>Cunich, Michelle</creatorcontrib><creatorcontrib>Dowie, Jack</creatorcontrib><creatorcontrib>Howard, Kirsten</creatorcontrib><creatorcontrib>Patel, Manish I</creatorcontrib><creatorcontrib>Mann, Graham</creatorcontrib><creatorcontrib>Lipworth, Wendy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salkeld, Glenn</au><au>Cunich, Michelle</au><au>Dowie, Jack</au><au>Howard, Kirsten</au><au>Patel, Manish I</au><au>Mann, Graham</au><au>Lipworth, Wendy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-04-06</date><risdate>2016</risdate><volume>11</volume><issue>4</issue><spage>e0152999</spage><epage>e0152999</epage><pages>e0152999-e0152999</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality.
To assess the effect of personalising the content of a decision aid for prostate cancer screening using the Prostate Specific Antigen (PSA) test.
Randomized controlled trial.
Australia.
1,970 men aged 40-69 years were approached to participate in the trial.
1,447 men were randomly allocated to either a standard decision aid with a fixed set of five attributes or a personalised decision aid with choice over the inclusion of up to 10 attributes.
To determine whether there was a difference between the two groups in terms of: 1) the emergent opinion (generated by the decision aid) to have a PSA test or not; 2) self-rated decision quality after completing the online decision aid; 3) their intention to undergo screening in the next 12 months. We also wanted to determine whether men in the personalised choice group made use of the extra decision attributes.
5% of men in the fixed attribute group scored 'Have a PSA test' as the opinion generated by the aid, as compared to 62% of men in the personalised choice group (χ2 = 569.38, 2df, p< 0001). Those men who used the personalised decision aid had slightly higher decision quality (t = 2.157, df = 1444, p = 0.031). The men in the personalised choice group made extensive use of the additional decision attributes. There was no difference between the two groups in terms of their stated intention to undergo screening in the next 12 months.
Together, these findings suggest that personalised decision support systems could be an important development in shared decision-making and patient-centered care.
Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612000723886.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27050101</pmid><doi>10.1371/journal.pone.0152999</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2016-04, Vol.11 (4), p.e0152999-e0152999 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1779033849 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Adult Aged Analysis Antigens Artificial intelligence Biology and Life Sciences Cancer Cancer screening Care and treatment Clinical decision making Clinical trials Customization Decision making Decision support systems Decision Support Techniques Diagnosis Health care costs Humans Internet Intervention Male Medical research Medical screening Medicine and Health Sciences Men Mens health Middle Aged Motivation Online Systems Patient Participation Prostate Prostate cancer Prostate specific antigen Prostate-Specific Antigen - blood Prostatic Neoplasms - diagnosis Public health Quality Quality assessment Randomization Research and Analysis Methods Screening Studies Systematic review |
| title | The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A10%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Personalised%20Choice%20in%20Decision%20Support:%20A%20Randomized%20Controlled%20Trial%20of%20an%20Online%20Decision%20Aid%20for%20Prostate%20Cancer%20Screening&rft.jtitle=PloS%20one&rft.au=Salkeld,%20Glenn&rft.date=2016-04-06&rft.volume=11&rft.issue=4&rft.spage=e0152999&rft.epage=e0152999&rft.pages=e0152999-e0152999&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0152999&rft_dat=%3Cgale_plos_%3EA453452078%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779033849&rft_id=info:pmid/27050101&rft_galeid=A453452078&rft_doaj_id=oai_doaj_org_article_b1ca67e863e34d988a5b450878198b46&rfr_iscdi=true |